Careers
CreaGen Biosciences is a young, dynamic company offering employment opportunities to qualified individuals in pursuit of excellence.

Employees are the key to our success and to our future. We offer competitive compensation packages, attractive working conditions and excellent career opportunities.

CreaGen Biosciences, Inc. is an Equal Opportunity Employer.

No positions are open currently.


How to Apply
Any interested and qualified person should send resume to: CreaGen Biosciences, Inc., 23 Rainin Road. Woburn, Massachusetts 01801 or E-mail: careers@creagenbio.com

Benefits
We offer industry competitive salaries and attractive benefit packages to all employees and their families.
Apply Online
Full Name :
Address :
City :
State/Province :
Country :
Zip Code :
Phone :
Email :
Upload Your Resume / CV :
 
   
   
 
News
  CreaGen Inc. makes into the 2018 list of major players in CRO industry
https://www.businesswire.com/news/home/20180412005808/en/Outsourcing-Drug-Discovery-Contract-Research-Organization-CRO https://themobileherald.com/contract-research-organization-market-industry-growth-and-forecast-analysis-report-till-2024/24870/ https://www.businesswire.com/news/home/20180412005808/en/Outsourcing-Drug-Discovery-Contract-Research-Organization-CRO   more...
    7th Advances In Chemical Sciences Symposium: May 4th, 2018
The Seventh Annual Advances in Chemical Sciences Symposium Royal Sonesta Hotel Cambridge, MA: May 4th, 2018 A day-long symposium focused on Medicinal Chemistry, Organic Synthesis, and Methodology, featuring eminent scientists from industry and academia. Speakers: Professor Richard R. Schrock (MIT): “TBA” Professor Dale L. Boger (Scripps Research Institute): “Redesign of Vancomycin for Resistant Bacteria” Professor Laura Kiessling (MIT): “TBA” Dr. Sue Ashwell (Forma Therapeutics): “Discovery and Optimization of a Novel Series of Inhibitors of mt-IDH1” Dr. Michael Hoemann (Abbvie): “Discovery and Optimization of Spleen Tyrosine Kinase Inhibitors for Immunological Diseases” Dr. Frank Salituro (Sage Therapeutics): “Discovery and Clinical Development of SAGE-217: A Next Generation Neuroactive Steroid Positive Allosteric Modulator of the (GABA)A Receptor” Plus: Vendor Exhibition Hall and Networking Reception   more...
 
 
Home  |  About Us  |  Services  |  Products  |  R&D  |  News  |  Careers  |  Contact us Copyright © 2013 CreaGen Biosciences Inc. All rights reserved.